Published in Clin Endocrinol (Oxf) on December 01, 1987
Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol (2003) 1.21
Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma. J Clin Invest (2017) 0.75
Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur J Clin Pharmacol (1979) 3.32
Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain (1975) 2.80
Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. Eur J Endocrinol (1997) 2.10
Reactions of nitrogen dioxide in aqueous model systems: oxidation of tyrosine units in peptides and proteins. Arch Biochem Biophys (1985) 2.08
Negative effects of famotidine on cardiac performance assessed by noninvasive hemodynamic measurements. Gastroenterology (1989) 2.07
The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism. Drug Metab Dispos (1996) 1.86
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
Changes in liver blood flow during enzyme induction. Biochem Pharmacol (1971) 1.65
Effect of small doses of iodine on thyroid function in patients with Hashimoto's thyroiditis residing in an area of mild iodine deficiency. Eur J Endocrinol (1998) 1.49
Response to methimazole in Graves' disease. The European Multicenter Study Group. Clin Endocrinol (Oxf) (1995) 1.44
[What is the recurrence rate for Basedow's disease treated with thyrostatic agents. Answers from a prospective study]. Schweiz Med Wochenschr (1990) 1.39
Determinants and impact of sleep duration in children and adolescents: data of the Kiel Obesity Prevention Study. Eur J Clin Nutr (2008) 1.38
A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. J Clin Endocrinol Metab (1993) 1.32
Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant (1998) 1.29
The influence of enzyme induction on polymorphic sparteine oxidation. Br J Clin Pharmacol (1986) 1.26
Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine. Klin Wochenschr (1982) 1.26
S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology (1999) 1.12
Urinary excretion of chlorothiazide in rats before and after phenobarbitone administration. Experientia (1972) 1.12
Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects. Eur J Clin Pharmacol (1988) 1.07
Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab (1990) 1.06
The effect of enzyme induction on diazepam metabolism in man. Br J Clin Pharmacol (1979) 1.05
Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci (1992) 1.05
Nonenzymatic deiodination of thyroid hormones by flavin mononucleotide and light. J Biol Chem (1966) 1.05
Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline. Klin Wochenschr (1987) 1.00
Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide. Eur J Clin Pharmacol (1988) 1.00
Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man. Eur J Clin Pharmacol (1983) 0.99
Control of prolactin secretion. Klin Wochenschr (1990) 0.99
Sensitive three-parameter flow-cytometric detection of abnormal cells in human cervical cancers: a pilot study. J Cancer Res Clin Oncol (1981) 0.98
Treatment of isolated gonadotropin deficiency in men with synthetic LR-RH and a more potent analogue of LH-RH. Neuroendocrinology (1977) 0.97
[Clinical pharmacokinetics of Articain after intraoral and intramuscular applications]. SSO Schweiz Monatsschr Zahnheilkd (1983) 0.96
Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy. Br J Dermatol (1999) 0.96
Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. Eur J Clin Pharmacol (1985) 0.96
Influence of ranitidine on plasma metoprolol and atenolol concentrations. Br Med J (Clin Res Ed) (1983) 0.95
Methods of the assessment of the effect of drugs on liver blood flow in man. Br J Clin Pharmacol (1979) 0.95
Hip fractures and the thyroid: a case-control study. J Intern Med (1995) 0.94
[Ranitidine-nifedipine interaction]. Dtsch Med Wochenschr (1984) 0.94
Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia. Eur J Clin Pharmacol (1974) 0.94
6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteine. Br J Clin Pharmacol (1982) 0.94
Large-scale preparation of highly purified pyrogen-free human growth hormone for clinical use. J Endocrinol (1979) 0.94
Enzyme induction and renal function in man. Br J Clin Pharmacol (1977) 0.94
Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest (1994) 0.93
Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis. Exp Clin Endocrinol Diabetes (2004) 0.93
Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs. Clin Endocrinol (Oxf) (1998) 0.92
Effect of aminophylline on cisplatin nephrotoxicity in the rat. Br J Pharmacol (1989) 0.92
Proceedings: Digoxin dosage in patients with impaired kidney function. Br J Pharmacol (1972) 0.92
Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man. Am J Physiol (1979) 0.92
Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease. Clin Pharmacokinet (1987) 0.92
Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. Ann N Y Acad Sci (1994) 0.91
Effects of various modes of androgen substitution therapy on erythropoiesis. Eur J Med Res (1997) 0.91
Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab (1997) 0.90
[Effect of cimetidine and ranitidine on the pharmacokinetics and anti-hypertensive effect of nifedipine]. Dtsch Med Wochenschr (1983) 0.90
Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin. Clin Pharmacol Ther (1979) 0.89
Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men. Metabolism (1999) 0.89
Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol (Copenh) (1990) 0.89
Effect of cisapride and metoclopramide on digoxin bioavailability. Eur J Drug Metab Pharmacokinet (1987) 0.88
Effects of pro- and antioxidative compounds on renal production of erythropoietin. Endocrinology (1999) 0.87
Influence of ranitidine on plasma metoprolol concentrations. Br Med J (Clin Res Ed) (1983) 0.87
Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metab (1996) 0.87
[Coincidence of non-medullary thyroid cancer and hyperparathyroidism]. Chirurg (1991) 0.86
Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats. Am J Physiol (1997) 0.86
Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clin Investig (1993) 0.86
Influence of coronary artery bypass surgery on thyroid hormone parameters. Horm Res (1997) 0.86
Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men. Clin Endocrinol (Oxf) (1996) 0.85
Treatment of Weber-Christian panniculitis with cyclosporine A. Rheumatol Int (1987) 0.85
Estimation of the biliary excretion of different cephalosporins utilizing retrograde cholangio-pancreatography (ERCP). Endoscopy (1981) 0.85
TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome'. Clin Endocrinol (Oxf) (1990) 0.85
The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study. Klin Wochenschr (1983) 0.84
Dysphagia due to transmural migration of surgical material into the esophagus nine years after Nissen fundoplication. Gastrointest Endosc (2000) 0.84
Congenital adrenal hyperplasia - how to improve the transition from adolescence to adult life. Exp Clin Endocrinol Diabetes (2004) 0.84
Santorini's duct--risk factor for acute pancreatitis or protective morphologic variant? Experiments in rabbits. Eur J Gastroenterol Hepatol (1997) 0.84
Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J Clin Endocrinol Metab (2001) 0.84
Clinical and biochemical aspects of the insulin autoimmune syndrome (IAIS). Klin Wochenschr (1986) 0.84
Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide). Exp Clin Endocrinol Diabetes (1999) 0.84
Successful treatment of meningioma with octreotide. Lancet (1989) 0.84
The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man. Eur J Clin Invest (1981) 0.83
Dose-dependence of the nifedipine-digoxin interaction? Clin Pharmacol Ther (1986) 0.83
A case of Behçet's syndrome presenting with Dieulafoy's ulcer. Z Gastroenterol (1997) 0.83
Selective bilateral and simultaneous catheterization of the inferior petrosal sinus: CRF stimulates prolactin secretion from ACTH-producing microadenomas in Cushing's disease. Clin Endocrinol (Oxf) (1988) 0.83
Divergent effects of different enzyme-inducing agents on endogenous and exogenous testosterone. Eur J Clin Pharmacol (1992) 0.83
Thyroid hormones enhance hypoxia-induced erythropoietin production in vitro. Exp Hematol (1994) 0.83
A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease. J Clin Endocrinol Metab (1990) 0.83
Quality of salivary tears following autologous submandibular gland transplantation for severe dry eye. Graefes Arch Clin Exp Ophthalmol (1999) 0.83
Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) (1993) 0.83
Allogenic bone marrow transplantation in adults: endocrine sequelae after 1-6 years. Acta Endocrinol (Copenh) (1989) 0.83
[Circulatory collapse caused by carbachol-containing eye drops]. Dtsch Med Wochenschr (1989) 0.83
Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolism. Br J Clin Pharmacol (1984) 0.83